CARDIOVASCULAR AND METABOLIC PHENOTYPES OF PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA

被引:0
|
作者
Pinna, Alessia [1 ]
Buralli, Simona [2 ]
Dalpiaz, Hermann [1 ]
Ubaldini, Giulia Mori [1 ]
Faconti, Luca [4 ]
Masi, Stefano [3 ]
Taddei, Stefano [3 ]
Bacca, Alessandra [2 ]
机构
[1] Univ Pisa, Dept Surg Pathol, Med, Mol & Crit Area, Pisa, Italy
[2] Azienda Osped Univ Pisana, Med 1, Pisa, Italy
[3] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[4] Kings Coll London, St Thomas Hosp, Dept Clin Pharmacol, London, England
关键词
D O I
10.1097/01.hjh.0001022480.41320.49
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients
    Cascon, Alberto
    Inglada-Perez, Lucia
    Comino-Mendez, Inaki
    de Cubas, Aguirre A.
    Leton, Rocio
    Mora, Jaume
    Marazuela, Monica
    Galofre, Juan Carlos
    Quesada-Charneco, Miguel
    Robledo, Mercedes
    ENDOCRINE-RELATED CANCER, 2013, 20 (03) : L1 - L6
  • [22] Predictors of malignancy and survival in patients with pheochromocytoma and paraganglioma
    Gonzalez-Sanchez, Hector Raul
    Aranda-Gutierrez, Alejandro
    Meraz-Brenez, Andres
    Verduzco-Aguirre, Haydee Cristina
    De la Pena-Lopez, Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1
    Gruber, Lucinda M.
    Erickson, Dana
    Babovic-Vuksanovic, Dusica
    Thompson, Geoffrey B.
    Young, William F., Jr.
    Bancos, Irina
    CLINICAL ENDOCRINOLOGY, 2017, 86 (01) : 141 - 149
  • [24] The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma
    Gruber, Lucinda M.
    Jasim, Sina
    Ducharme-Smith, Allison
    Weingarten, Toby
    Young, William F., Jr.
    Bancos, Irina
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (06): : E2393 - E2401
  • [25] Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma
    Forrer, F.
    Riedweg, I.
    Maecke, H. R.
    Mueller-Brand, J.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 52 (04): : 334 - 340
  • [26] Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma
    Dhir, Mashaal
    Li, Wei
    Hogg, Melissa E.
    Bartlett, David L.
    Carty, Sally E.
    McCoy, Kelly L.
    Challinor, Sue M.
    Yip, Linwah
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3624 - 3630
  • [27] Systemic therapy for patients with metastatic pheochromocytoma and paraganglioma
    Fischer, Alessa
    del Rivero, Jaydira
    Wang, Katharina
    Noelting, Svenja
    Jimenez, Camilo
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 39 (01)
  • [28] SURVIVAL DIFFERENCES BETWEEN PHEOCHROMOCYTOMA AND PARAGANGLIOMA PATIENTS
    Incesu, Reha-Baris
    Morra, Simone
    Scheipner, Lukas
    Baudo, Andrea
    Jannello, Letizia Maria Ippolita
    Siech, Carolin
    de Angelis, Mario
    Tian, Zhe
    Saad, Fred
    Shariat, Shahrokh F.
    de Cobelli, Ottavio
    Chun, Felix K. H.
    Carmignani, Luca
    Briganti, Alberto
    Ahyai, Sascha
    Longo, Nicola
    Tilki, Derya
    Graefen, Markus
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E525 - E526
  • [29] RESULTS OF GENETIC TESTING IN PATIENTS WITH PHEOCHROMOCYTOMA/PARAGANGLIOMA
    Zelinka, T.
    Vicha, A.
    Musil, Z.
    Widimsky, J., Jr.
    JOURNAL OF HYPERTENSION, 2019, 37 : E40 - E40
  • [30] Predictors of hemodynamic instability in patients with pheochromocytoma and paraganglioma
    Ma, Lulu
    Shen, Le
    Zhang, Xiuhua
    Huang, Yuguang
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (04) : 803 - 808